SNAP Forecasts 1B Monthly Active Users In Next 2-3 Years

– CNBC- CNBC

– CNBC

– CNBC

Total
0
Shares
Related Posts
Read More

Enanta Pharmaceuticals Presents New Preclinical Data For EDP-235, Its Oral, Direct-Acting Antiviral Protease Inhibitor Specifically Designed For The Treatment Of COVID-19 At IDWeek 2022 On October 21

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced new preclinical data supporting

ENTA